Flagship Pioneering, the VC fund run by Moderna’s co-founder Noubar Afeyan has launched a new biotech Laronde, with an ambitious plan to create a new class of drugs based on Endless RNA.

Idorsia Pharmaceuticals has claimed FDA approval for aprocitentan as a treatment for resistant hypertension, becoming the first drug in the endothelin receptor antagonist class for that indication.

SOURCE: IQVia Total Patient Tracker (TPT) Database, Year 2017, Extracted April 2018.

5-hydroxytriptamine is a key mediator in the pathogenesis of migraine and thus 5-HT 1-receptor agonists are the principal drugs for acute migraine therapy. There are three classes of drugs for ...